Skip to content

Clinical trials

Phase 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 4 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20052
20082
20092
20102
20111
20134
20143
20152
20163
20191
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status6
Terminated4
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
Cttq1
Dong-A ST Co., Ltd.1
Dong-Wook Kim1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Hospital Universitario Dr. Jose E. Gonzalez1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
King Abdullah International Medical Research Center1
PETHEMA Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive29
Leukemia4
Blast Crisis2
Bronchiolitis Obliterans Syndrome2
Gastrointestinal Stromal Tumors2
Chromosome Aberrations1
Dwarfism1
Leukemia, Myeloid, Chronic-Phase1
Myeloproliferative Disorders1
Philadelphia Chromosome1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.